Indication examples
- Depressed tibia plateau fracture
- Radius fracture
- Pseudarthrosis
- Cyst fillings
- Spinal stabilisation
- Defect fill after tumour removal
- Acetabulum reconstruction
- Displacement osteotomy
- Pathologic fractures
- Bone necrosis
NanoBone® Indication examples
A clinical study showed that NanoBone® provides results regarding to complications and fracture healing rates that are at least comparable with the use of allograft.
NanoBone® ALIF study
Status before surgery
6 months after surgery
A prospective randomised ALIF study showed that NanoBone® yields results that are comparable to those of an allograft. After 6 months, a fusion rate of 96% was reached in the NanoBone® group.
NanoBone® PLIF study
Intercorporal spinal fusion with L3-4 connection instability after L4-S1 fusion, 9 months after surgery
Intercorporal L5-S1 spinal fusion, 9 months after surgery
Multisegmental degenerative L2-S1 instability, 9 months after surgery
A prospective CT-controlled clinical study on intercorporal fusion showed a fusion rate of 90 % (27 out of 30 segments) after 9 months.
The clinical Oswestry Disability Index (ODI) gained 28% for the total collective, the value for the Visual Analog Scores (VAS) even 47%.
Femoral shaft fracture
Before surgery
After surgery
Follow-up after 1 year
Infected tibial fracture
Infection cleaning with Septopal chains
Defect fill with NanoBone®
after infection cleaning
Follow-up after 1 year
Giant cell tumour with cement filling
Before surgery
Defect fill with 50 ml
NanoBone® Putty after surgery
18 weeks after surgery